LyP-2
Cat.No:CLP1207 Solarbio
CAS:850859-24-4
Molecular Formula:C37H69N17O12S2
Molecular Weight:1008.18
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
{{cart_num}}
My CartCAS:850859-24-4
Molecular Formula:C37H69N17O12S2
Molecular Weight:1008.18
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
Product Type | Peptides |
CAS | 850859-24-4 |
Sequence(1LC) | CNRRTKAGC |
Sequence(3LC) | Cys-Asn-Arg-Arg-Thr-Lys-Ala-Gly-Cys |
Molecular Formula | C37H69N17O12S2 |
Molecular Weight | 1008.18 |
Purity | ≥95% |
Appearance | Lyophilized powder |
Salt Form | Trifluoroacetate salt |
Source | Synthetic |
Storage | Store at -20℃,2 years.(Avoid freeze/thaw cycles) |
Category/Label | Cancer Research |
Background | LyP-2 is a peptide that homes to tumor lymphatics. LyP2 homes to lymphatics of C8161 melanomas and cervical carcinomas and K14-HPV16 skin, but not to MDA-MB435 tumors, showing heterogeneity in the molecular markers of tumor cells and lymphatics. |
Reference | [1]. Kebebe D, et al. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers. Int J Nanomedicine. 2018 Mar 9;13:1425-1442. [2]. Laakkonen P, et al. Peptide targeting of tumor lymph vessels. Ann N Y Acad Sci. 2008;1131:37-43. |
Unit | Bottle |
Specification | 1mg 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.